![Cara Ferreira](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cara Ferreira
Responsable des Ressources Humaines chez
FUSN PHAR
Profil
Cara Ferreira is currently the Chief of Staff at Fusion Pharmaceuticals, Inc. Her former job was as the President-Radiopharmaceuticals Science Council at the Society of Nuclear Medicine & Molecular Imaging.
She holds an MBA and a doctorate from the University of British Columbia.
Postes actifs de Cara Ferreira
| Sociétés | Poste | Début |
|---|---|---|
| FUSN PHAR | Responsable des Ressources Humaines | 01/11/2020 |
Anciens postes connus de Cara Ferreira
| Sociétés | Poste | Fin |
|---|---|---|
Society of Nuclear Medicine & Molecular Imaging
 Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Corporate Officer/Principal | - |
Formation de Cara Ferreira
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Society of Nuclear Medicine & Molecular Imaging
Society of Nuclear Medicine & Molecular Imaging Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit scientific and professional organization that promotes the science, technology and practical application of nuclear medicine and molecular imaging | Commercial Services |
Fusion Pharmaceuticals, Inc.
 Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
